Andrew Bollen

Andrew Bollen is a faculty member at the University of California San Francisco, specializing in neuropathology. His research focuses on central nervous system tumors, infections, and muscle/nerve pathology, with a dual MD (University of California San Diego) and DVM (University of California Davis School of Veterinary Medicine) background.

• Education:
  • A.B. in Biology, Harvard College (1975)
  • D.V.M., University of California Davis School of Veterinary Medicine (1980)
  • M.D., University of California San Diego School of Medicine (1985)

His work bridges human and veterinary medicine, emphasizing genetic mutations (e.g., SOX10 indels, FET-CREB fusions) in brain tumors like glioblastoma, schwannomas, and CNS lymphomas. Recent studies explore immune checkpoint therapies, tumor evolution, and epigenetic classifications.

Publications highlight molecular profiling of glioblastoma subtypes, schwannomatosis genetics, and neuroinfectious diseases. Collaborative efforts span neurosurgery, oncology, and immunology departments.

Scientific Honors:
• Phi Zeta Honor Society (1980)
• A. Baird Hastings Society (1985)
• Castle Connolly Guide: Top Doctors (2001-present) and Cancer Specialists (2005-present)

Bollen contributes to refining CNS tumor diagnostics through multiplatform molecular analyses and identifies novel therapeutic targets in gliomas and rare posttransplant disorders.